Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s43018-021-00216-6
PubMed Identifier: 34423310
Publication URI: http://europepmc.org/abstract/MED/34423310
Type: Journal Article/Review
Parent Publication: Nature Cancer
Issue: 8
ISSN: 2662-1347